Oncotarget

Retraction:

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells

PDF  |  How to cite

Oncotarget. 2025; 16:874-874. https://doi.org/10.18632/oncotarget.28800

Metrics: PDF 23 views  |   ?  

Giuliana Gatti1,*, Valeria Lucini2,*, Silvana Dugnani2, Angela Calastretti1, Gilberto Spadoni3, Annalida Bedini3, Silvia Rivara4, Marco Mor4, Gianfranco Canti1, Francesco Scaglione2, Annamaria Bevilacqua1

1 Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy
2 Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy
3 Department of Biomolecular Sciences, Università degli Studi di Urbino “Carlo Bo”, Urbino, Italy
4 Department of Food and Drug, Università degli Studi di Parma, Parma, Italy
* Authors contributed equally to this work

Published: December 31, 2025

Copyright: © 2025 Gatti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget conducted an investigation into this paper after concerns were raised regarding Figure 5A, which contains three images of the same tumor, but described as a single photograph. The authors acknowledged this error as unintentional but agreed that it “affects profoundly the quality of the paper.” Additionally, we found several duplicated images of Western blots in Figures 7 and 8:
Figure 7A: The Akt image in DMSO-treated DX3 cells duplicates the tubulin image from UCM1037-treated cells.
Figure 7A: The Bax image from DMSO-treated DX3 cells duplicates the Bax image from DMSO-treated MCF-7 cells in Figure 8A.
Figure 7B: Two tubulin images (WM-115 cells) overlap with tubulin images in Figure 8A (MCF-7 cells).
In light of these irregularities, the Editorial decision was made to retract this article. Authors G. Spadoni, A. Bedini, S. Rivara, M. Mor, V. Lucini, and S. Dugnani have agreed to the retraction, stating that “improper modification of experimental images is a problem for data reliability and can affect the credibility of the paper. For this reason the undersigned authors ask for a formal retraction of the article, to preserve the scientific reputation of themselves and of their institutions.”

Original article: Oncotarget. 2017; 8:68338–68353. DOI: https://doi.org/10.18632/oncotarget.20124.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28800